Trials / Conditions / Advanced Nonhematologic Malignancies
Advanced Nonhematologic Malignancies
5 registered clinical trials studyying Advanced Nonhematologic Malignancies.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult NCT02327169 | Millennium Pharmaceuticals, Inc. | Phase 1 |
| Withdrawn | Study of TAK-733 in Combination With Alisertib in Adult Patients With Advanced Nonhematologic Malignancies NCT01613261 | Millennium Pharmaceuticals, Inc. | Phase 1 |
| Completed | A Safety and Pharmacokinetic Study of TAK-228 in Combination With TAK-117 in Adult Participants With Advanced NCT01899053 | Millennium Pharmaceuticals, Inc. | Phase 1 |
| Completed | A Study of TAK-441 in Adult Patients With Advanced Nonhematologic Malignancies NCT01204073 | Millennium Pharmaceuticals, Inc. | Phase 1 |
| Completed | Study of MLN4924 in Adult Patients With Nonhematologic Malignancies NCT00677170 | Millennium Pharmaceuticals, Inc. | Phase 1 |